Transcriptional Profiling of Exosomes Defines Molecular Phenotype of Preclampsia

Information

  • Research Project
  • 10145040
  • ApplicationId
    10145040
  • Core Project Number
    P20GM121298
  • Full Project Number
    5P20GM121298-05
  • Serial Number
    121298
  • FOA Number
    PAR-14-035
  • Sub Project Id
    7785
  • Project Start Date
    4/1/2017 - 7 years ago
  • Project End Date
    2/28/2022 - 3 years ago
  • Program Officer Name
  • Budget Start Date
    3/1/2021 - 4 years ago
  • Budget End Date
    2/28/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    05
  • Suffix
  • Award Notice Date
    4/6/2021 - 3 years ago

Transcriptional Profiling of Exosomes Defines Molecular Phenotype of Preclampsia

Project Summary Abstract Preeclampsia is a multi-system hypertensive disorder of pregnancy affecting 2-8 % of deliveries in the US. It is characterized by variable degrees of maternal symptoms including elevated blood pressure, proteinuria and fetal growth retardation. Preeclampsia is one of the most common causes of fetal and maternal morbidity and mortality worldwide. There is currently no effective intervention for preeclampsia short of delivery of the fetus, thus preeclampsia is a leading cause of premature birth. Large-scale molecular profiling technologies permit the identification of disease mechanisms and understanding of underlying cellular processes. It is now known that nearly all tissues and cell types release vesicles from their plasma membrane. The contents of extracellular vesicles, including both mRNA and miRNA, are tissue specific, can be translated into proteins by target cells and that those RNAs can be functionally transferred to recipient cells and lead to alterations in downstream signaling. We hypothesize that the mechanism for severe preeclampsia can be revealed by comparing the transcript profile of the extracellular vesicles from the whole blood of women diagnosed with the disorder prior to delivery of the fetus versus gestational age matched normotensive women not in labor. We will use innovative bioinformatics techniques to analyze differential expression and to deconstruct the transcription profiles of the exosomal cargo into the contribution from their tissues of origin. Identification of the transcript profiles in these extracellular vesicles will provide insights into the mechanisms and pathogenesis of severe preeclampsia and lead to new strategies for treatment, prediction and prevention.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    P20
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    146189
  • Indirect Cost Amount
    115166
  • Total Cost
  • Sub Project Total Cost
    261355
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIGMS:261355\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZGM1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    WOMEN AND INFANTS HOSPITAL-RHODE ISLAND
  • Organization Department
  • Organization DUNS
    069851913
  • Organization City
    PROVIDENCE
  • Organization State
    RI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    029052499
  • Organization District
    UNITED STATES